Shots: The independent DSMB recommended pausing the enrollment of the ACTIV-3 clinical trial. The trial is evaluating Lilly’s bamlanivimab (LY-CoV555, 7000mg) + remdesivir as a treatment for COVID-19 in hospitalized patients, and is sponsored by the NIAID Lilly trusts the judgment & supports independent DSMB decisions to exercise caution in ensuring the safety of the […]Read More
Shots: Pfizer and Mylan delayed the closing of the Viatris merger (a merger b/w Upjohn and Mylan) due to the unprecedented circumstances amid COVID-19 pandemic, including associated delays in the regulatory review process The companies anticipated the merger to be closed in H2’20 with no expected changes in the deal terms and Mylan’s EGM moved […]Read More
Shots: Smith Medical has recalled its Medfusion 4000 syringe pump with firmware version 1.7.0 due to malfunctioning alarms and potential interruption of therapy. The FDA has labeled it as Class I recall The 627 devices have recalled having model numbers are 4000-0107-01 and 4000-0106-01, manufactured on Jun 25, 2019, and distributed b/w Sept 27, 2019, […]Read More
Copyright ©2021 PharmaShots | Powered by Octavus Consulting
